$110,14
-$0,09(-0,08%)
*Data last updated: 2026-04-28 19:11 (UTC+8)
As of 2026-04-28 19:11, Merck (US) (MRK) is priced at $110,14, with a total market cap of $272,55B, a P/E ratio of 14,45, and a dividend yield of 3,01%. Today, the stock price fluctuated between $109,88 and $111,90. The current price is 0,23% above the day's low and 1,57% below the day's high, with a trading volume of 7,10M. Over the past 52 weeks, MRK has traded between $73,31 to $125,14, and the current price is -11,98% away from the 52-week high.
MRK Key Stats
Yesterday's Close$111,90
Market Cap$272,55B
Volume7,10M
P/E Ratio14,45
Dividend Yield (TTM)3,01%
Dividend Amount$0,85
Diluted EPS (TTM)7,33
Net Income (FY)$18,25B
Revenue (FY)$65,01B
Earnings Date2026-10-29
EPS Estimate2,40
Revenue Estimate$17,54B
Shares Outstanding2,43B
Beta (1Y)0.275
Ex-Dividend Date2026-03-16
Dividend Payment Date2026-04-07
About MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
SectorHealthcare
IndustryDrug Manufacturers - General
CEORobert Davis
HeadquartersRahway,NJ,US
Official Websitehttps://www.merck.com
Employees (FY)75,00K
Average Revenue (1Y)$866,81K
Net Income per Employee$243,38K
Merck (US) (MRK) FAQ
What's the stock price of Merck (US) (MRK) today?
x
Merck (US) (MRK) is currently trading at $110,14, with a 24h change of -0,08%. The 52-week trading range is $73,31–$125,14.
What are the 52-week high and low prices for Merck (US) (MRK)?
x
What is the price-to-earnings (P/E) ratio of Merck (US) (MRK)? What does it indicate?
x
What is the market cap of Merck (US) (MRK)?
x
What is the most recent quarterly earnings per share (EPS) for Merck (US) (MRK)?
x
Should you buy or sell Merck (US) (MRK) now?
x
What factors can affect the stock price of Merck (US) (MRK)?
x
How to buy Merck (US) (MRK) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
